Literature DB >> 26104084

Genetics of anaplastic large cell lymphoma.

Yu Zeng1,2, Andrew L Feldman1.   

Abstract

Anaplastic large cell lymphoma (ALCL) comprises a group of T-cell non-Hodgkin lymphomas unified by common morphologic and immunophenotypic characteristics, but with a spectrum of clinical presentations and behaviors. Early identification of anaplastic lymphoma kinase (ALK) gene rearrangements in some ALCLs led to recognition of ALK as an important diagnostic and prognostic biomarker, and a key driver of ALCL pathobiology. Rearrangements and other genetic abnormalities of ALK subsequently were identified in diverse other human malignancies. Recent clinical, pathologic, and genetic data have begun to shed light on ALK-negative ALCLs, revealing significant heterogeneity within this more ill-defined entity.

Entities:  

Keywords:  Anaplastic large cell lymphoma; DUSP22; T-cell non-Hodgkin lymphoma; anaplastic lymphoma kinase (ALK); genetics; p63

Mesh：

Substances：

Year:  2015        PMID： 26104084      PMCID： PMC4732699          DOI： 10.3109/10428194.2015.1064530

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


  59 in total

1.  Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.

Authors:  Marchina F Benner; Erica Ballabio; Marloes S van Kester; Nigel J Saunders; Maarten H Vermeer; Rein Willemze; Charles H Lawrie; Cornelis P Tensen
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

2.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

3.  Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS.

Authors:  Qian Zhang; Hongyi Wang; Kanchan Kantekure; Jennifer C Paterson; Xiaobin Liu; Andras Schaffer; Chrystal Paulos; Michael C Milone; Niels Odum; Suzanne Turner; Teresa Marafioti; Mariusz A Wasik
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

4.  Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.

Authors:  Andrew P Sciallis; Mark E Law; David J Inwards; Rebecca F McClure; William R Macon; Paul J Kurtin; Ahmet Dogan; Andrew L Feldman
Journal:  Mod Pathol       Date:  2012-03-02       Impact factor: 7.842

5.  miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.

Authors:  Hironori Matsuyama; Hiroshi I Suzuki; Hikaru Nishimori; Masaaki Noguchi; Takashi Yao; Norio Komatsu; Hiroyuki Mano; Koichi Sugimoto; Kohei Miyazono
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

6.  Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

Authors:  David A Wada; Mark E Law; Eric D Hsi; David J Dicaudo; Linglei Ma; Megan S Lim; Aieska de Souza; Nneka I Comfere; Roger H Weenig; William R Macon; Lori A Erickson; Nazan Ozsan; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Mod Pathol       Date:  2010-12-17       Impact factor: 7.842

7.  C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC.

Authors:  Hiroshi Moritake; Hidemi Shimonodan; Kousuke Marutsuka; Sachiyo Kamimura; Hitomi Kojima; Hiroyuki Nunoi
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

Review 8.  Anaplastic lymphoma kinase in human cancer.

Authors:  Antonella Barreca; Elena Lasorsa; Ludovica Riera; Rodolfo Machiorlatti; Roberto Piva; Maurilio Ponzoni; Ivo Kwee; Francesco Bertoni; Pier Paolo Piccaluga; Stefano A Pileri; Giorgio Inghirami
Journal:  J Mol Endocrinol       Date:  2011-07-04       Impact factor: 5.098

9.  Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.

Authors:  Elodie Laharanne; Naïma Oumouhou; Françoise Bonnet; Martina Carlotti; Catherine Gentil; Edith Chevret; Thomas Jouary; Michel Longy; Béatrice Vergier; Marie Beylot-Barry; Jean-Philippe Merlio
Journal:  J Invest Dermatol       Date:  2010-02-04       Impact factor: 8.551

10.  C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.

Authors:  Natasa Anastasov; Irina Bonzheim; Martina Rudelius; Margit Klier; Therese Dau; Daniela Angermeier; Justus Duyster; Stefania Pittaluga; Falko Fend; Mark Raffeld; Leticia Quintanilla-Martinez
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941
View more
  10 in total

1.  Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.

Authors:  Rebecca A Luchtel; Surendra Dasari; Naoki Oishi; Martin Bjerregård Pedersen; Guangzhen Hu; Karen L Rech; Rhett P Ketterling; Jagmohan Sidhu; Xueju Wang; Ryohei Katoh; Ahmet Dogan; N Sertac Kip; Julie M Cunningham; Zhifu Sun; Saurabh Baheti; Julie C Porcher; Jonathan W Said; Liuyan Jiang; Stephen Jacques Hamilton-Dutoit; Michael Boe Møller; Peter Nørgaard; N Nora Bennani; Wee-Joo Chng; Gaofeng Huang; Brian K Link; Fabio Facchetti; James R Cerhan; Francesco d'Amore; Stephen M Ansell; Andrew L Feldman
Journal:  Blood       Date:  2018-08-09       Impact factor: 22.113

2.  Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.

Authors:  Rebecca L Boddicker; Gina L Razidlo; Surendra Dasari; Yu Zeng; Guangzhen Hu; Ryan A Knudson; Patricia T Greipp; Jaime I Davila; Sarah H Johnson; Julie C Porcher; James B Smadbeck; Bruce W Eckloff; Daniel D Billadeau; Paul J Kurtin; Mark A McNiven; Brian K Link; Stephen M Ansell; James R Cerhan; Yan W Asmann; George Vasmatzis; Andrew L Feldman
Journal:  Blood       Date:  2016-06-13       Impact factor: 22.113

Review 3.  Genomics of LGL leukemia and select other rare leukemia/lymphomas.

Authors:  Katharine B Moosic; Umadevi Paila; Kristine C Olson; Karolina Dziewulska; T Tiffany Wang; Jeffrey C Xing; Aakrosh Ratan; David J Feith; Thomas P Loughran; Thomas L Olson
Journal:  Best Pract Res Clin Haematol       Date:  2019-06-06       Impact factor: 3.020

Review 4.  Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management.

Authors:  Nabila Bennani-Baiti; Stephen Ansell; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2015-12-11       Impact factor: 2.929

5.  PATRI, a Genomics Data Integration Tool for Biomarker Discovery.

Authors:  G Ukmar; G E M Melloni; L Raddrizzani; P Rossi; S Di Bella; M R Pirchio; M Vescovi; A Leone; M Callari; M Cesarini; A Somaschini; G Della Vedova; M G Daidone; M Pettenella; A Isacchi; R Bosotti
Journal:  Biomed Res Int       Date:  2018-06-28       Impact factor: 3.411

6.  The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK- anaplastic large cell lymphoma by regulating the DNA helicase HELLS.

Authors:  Valentina Fragliasso; Akanksha Verma; Gloria Manzotti; Annalisa Tameni; Rohan Bareja; Tayla B Heavican; Javeed Iqbal; Rui Wang; Danilo Fiore; Valentina Mularoni; Wing C Chan; Priscillia Lhoumaud; Jane Skok; Eleonora Zanetti; Francesco Merli; Alessia Ciarrocchi; Oliver Elemento; Giorgio Inghirami
Journal:  Leukemia       Date:  2020-03-02       Impact factor: 11.528

Review 7.  Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature.

Authors:  Qinghua Cao; Fang Liu; Shurong Li; Ni Liu; Lihui Li; Changzhao Li; Tingsheng Peng
Journal:  Diagn Pathol       Date:  2016-09-09       Impact factor: 2.644

Review 8.  The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).

Authors:  Ivonne A Montes-Mojarro; Julia Steinhilber; Irina Bonzheim; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Cancers (Basel)       Date:  2018-04-04       Impact factor: 6.639

Review 9.  Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.

Authors:  Valentina Giudice; Francesca Mensitieri; Viviana Izzo; Amelia Filippelli; Carmine Selleri
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

Review 10.  The State of the Art about Etiopathogenetic Models on Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): A Narrative Review.

Authors:  Roberto Cuomo
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.